Next Article in Journal
The Uncharted Landscape of Rare Endocrine Immune-Related Adverse Events
Next Article in Special Issue
Fibroblasts as Playmakers of Cancer Progression: Current Knowledge and Future Perspectives
Previous Article in Journal
Filling the Gap after CDK4/6 Inhibitors: Novel Endocrine and Biologic Treatment Options for Metastatic Hormone Receptor Positive Breast Cancer
Previous Article in Special Issue
Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy
 
 
Review

Article Versions Notes

Cancers 2023, 15(7), 2014; https://doi.org/10.3390/cancers15072014
Action Date Notes Link
article xml file uploaded 28 March 2023 12:00 CEST Original file -
article xml uploaded. 28 March 2023 12:00 CEST Update https://www.mdpi.com/2072-6694/15/7/2014/xml
article pdf uploaded. 28 March 2023 12:00 CEST Version of Record https://www.mdpi.com/2072-6694/15/7/2014/pdf
article html file updated 28 March 2023 12:01 CEST Original file -
article html file updated 28 March 2023 12:01 CEST Update -
article html file updated 6 April 2023 23:09 CEST Update https://www.mdpi.com/2072-6694/15/7/2014/html
Back to TopTop